Susquehanna Fundamental Investments’s AYTU BioPharma AYTU Stock Holding History

Susquehanna Fundamental Investments’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$58K	Sell	2,677 -904	-25%	-$22.5K	﹤0.01%	1484
2021 Q4	$97K	Sell	3,581 -462	-11%	-$20K	﹤0.01%	1337
2021 Q3	$233K	Buy	4,043 +1,302	+48%	+$97.7K	﹤0.01%	1489
2021 Q2	$275K	Buy	2,741 +691	+34%	+$81.1K	0.01%	1397
2021 Q1	$312K	Buy	+2,050	New	+$325K	0.01%	1282

Other funds holding AYTU

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna Fundamental Investments's AYTU Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its AYTU BioPharma (AYTU) stake by 25% in Q1 2022, selling an estimated $22.5K and leaving 2,677 shares worth $58K. The position accounts for ﹤0.01% of the portfolio, ranked #1484.

Susquehanna Fundamental Investments first reported a position in AYTU in Q1 2021 and has held it in 5 quarters since. The position peaked at $312K in Q1 2021. 32 funds tracked by Wall St. Rank hold AYTU as of Q1 2022.

Susquehanna Fundamental Investments held 2,677 shares of AYTU BioPharma worth $58K as of Q1 2022.
Susquehanna Fundamental Investments sold 904 AYTU BioPharma shares in Q1 2022, an estimated $22.5K.
AYTU BioPharma made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1484 holding.
Susquehanna Fundamental Investments first reported a position in AYTU BioPharma in Q1 2021 and has held it in 5 quarters since.
Susquehanna Fundamental Investments's AYTU BioPharma position peaked at $312K in Q1 2021.
32 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.